Showing 461 - 480 results of 115,472 for search '(( a non decrease ) OR ( 5 ((((step decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 1.62s Refine Results
  1. 461
  2. 462
  3. 463

    NAC prevents VMH GI neuron activation by decreased glucose. by Xavier Fioramonti (371172)

    Published 2013
    “…(B) Percentage of VMH GI neurons from S<sup>3</sup>S or I<sup>3</sup>S rats pre-treated or not with NAC which depolarized in response to a 2.5–0.7 mM glucose decrease quantified using changes in FLIPR-MPD fluorescence intensity. *: p<0.05 (Two-way ANOVA; group differences were determined by One-Way ANOVA followed by Bonferoni post-hoc test).…”
  4. 464
  5. 465

    Hematopoietic potential decreases in ESC with down-regulation of junction molecules. by Basha L. Stankovich (207031)

    Published 2011
    “…CD45 expression was analyzed flow cytometrically using anti-CD45 conjugated to PerCP-Cy5.5. Non-viable cells were excluded based on DAPI fluorescence. …”
  6. 466

    Loss of Cntnap2 decreases specifically stabilization of new spines. by Amos Gdalyahu (3213810)

    Published 2015
    “…<p><b>a.</b> From left to right: Chronic imaging through a cranial window of L5 pyramidal neuron. …”
  7. 467
  8. 468
  9. 469
  10. 470

    Wnt5a expressing tumors demonstrate a decrease in markers of the basal tumor subtype. by Stephanie L. Easter (662168)

    Published 2014
    “…Values are means +/− standard error (n = 6 MMTV-Wnt1, 3 fields per tumor; n = 5 MMTV-Wnt1;MMTV-Wnt5a, 3 fields per tumor). MMTV-Wnt1;MMTV-Wnt5a tumors demonstrated a significant decrease in K6-expressing cells as measured by T-test (* = p<0.05).…”
  11. 471
  12. 472

    Image 5_Behavioral and biochemical changes associated with the analgesic effects of (2R,6R)-hydroxynorketamine alone and in combination with meloxicam following disk puncture in mi... by Vaskar Das (21529538)

    Published 2025
    “…Our finding supports further study of the clinical potential of (2R,6R)-Hydroxynorketamine as a non-opioid analgesic for discogenic back pain.…”
  13. 473
  14. 474
  15. 475
  16. 476
  17. 477
  18. 478
  19. 479

    Image_2_Serum Zinc-α2-Glycoprotein Levels Were Decreased in Patients With Premature Coronary Artery Disease.JPEG by Meijuan Liu (4924417)

    Published 2019
    “…At the cutoff value of 7.955 μg/mL serum ZAG, the sensitivity and specificity for differentiating patients with PCAD from controls were 50.5 and 78.0%, respectively. The combination of ZAG with other clinical variables including age, gender, BMI, SBP, FBG, TC, HDL-C, Cr, and Urea had significantly improved the diagnosis accuracy with a sensitivity of 82.6%, a specificity of 95.0%, and AUC of 0.957 (95% CI, 0.940–0.975, p < 0.05).…”
  20. 480

    Image_1_Serum Zinc-α2-Glycoprotein Levels Were Decreased in Patients With Premature Coronary Artery Disease.JPEG by Meijuan Liu (4924417)

    Published 2019
    “…At the cutoff value of 7.955 μg/mL serum ZAG, the sensitivity and specificity for differentiating patients with PCAD from controls were 50.5 and 78.0%, respectively. The combination of ZAG with other clinical variables including age, gender, BMI, SBP, FBG, TC, HDL-C, Cr, and Urea had significantly improved the diagnosis accuracy with a sensitivity of 82.6%, a specificity of 95.0%, and AUC of 0.957 (95% CI, 0.940–0.975, p < 0.05).…”